2096

COM:SIMCERE

Simcere Pharmaceutical Group

  • Stock

Last Close

6.78

22/11 08:08

Market Cap

14.37B

Beta: -

Volume Today

3.31M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
497.28M
-
929.04M
86.82%
1.08B
16.44%
805.09M
25.58%
1.40B
74.12%
888.15M
36.64%
714.76M
19.52%
depreciation and amortization
104.14M
-
120.00M
15.23%
162.51M
35.42%
222.33M
36.81%
251.81M
13.26%
282.93M
12.36%
deferred income tax
47.44M
-
-231.63M
588.22%
-265.77M
14.74%
-574.64M
116.22%
-1.12B
94.70%
-8.28M
99.26%
stock based compensation
15.15M
-
5.70M
62.41%
14.15M
148.48%
32.80M
131.76%
62.39M
90.24%
138.29M
121.65%
12.12M
91.24%
change in working capital
244.95M
-
-55.44M
122.63%
-290.88M
424.70%
-462.18M
58.89%
-769.25M
66.44%
79.07M
110.28%
accounts receivables
-386.39M
-
-542.15M
40.31%
-545.20M
0.56%
74.84M
113.73%
inventory
20.22M
-
-49.20M
343.31%
-20.05M
59.24%
-35.46M
76.86%
-8.33M
76.51%
-116.79M
1,302.09%
accounts payables
386.39M
-
542.15M
40.31%
545.20M
0.56%
-74.84M
113.73%
other working capital
224.73M
-
-6.24M
102.78%
-270.83M
4,238.83%
-426.72M
57.56%
-760.92M
78.32%
195.87M
125.74%
other non cash items
30.11M
-
8.14M
72.95%
70.98M
771.51%
73.33M
3.32%
-29.92M
140.79%
-25.46M
14.90%
-726.88M
2,755.10%
net cash provided by operating activities
939.08M
-
775.82M
17.39%
772.80M
0.39%
96.73M
87.48%
-201.97M
308.80%
1.35B
770.75%
investments in property plant and equipment
-292.20M
-
-335.22M
14.72%
-507.66M
51.44%
-352.84M
30.50%
-209.49M
40.63%
-678.00M
223.65%
acquisitions net
-10.20M
-
-20M
96.08%
-154.31M
671.54%
120.18M
177.88%
44.65M
62.85%
335.19M
650.77%
purchases of investments
-1.41B
-
-896.71M
36.30%
-1.67B
86.28%
-103.77M
93.79%
-1.49B
1,335.26%
-344.79M
76.85%
sales maturities of investments
804.69M
-
1.15B
43.42%
974.75M
15.54%
764.57M
21.56%
451.12M
41.00%
824.29M
82.72%
other investing activites
397.08M
-
-374.55M
194.32%
764.69M
304.16%
100.95M
86.80%
767.62M
660.38%
-68.38M
108.91%
net cash used for investing activites
-508.39M
-
-472.40M
7.08%
-592.93M
25.51%
529.08M
189.23%
-435.50M
182.31%
68.31M
115.68%
debt repayment
-843.75M
-
-982.17M
16.40%
-2.03B
106.21%
-1.82B
9.90%
-2.46B
35.01%
-1.18B
51.94%
common stock issued
-4.39M
-
13.85M
415.47%
43.91M
217.06%
3.01B
6,750.22%
common stock repurchased
1.88B
-
2.43B
29.75%
dividends paid
-549.06M
-
-912.05M
66.11%
-391.30M
-
-391.30M
0%
other financing activites
500.82M
-
-48.00M
109.58%
-554.42M
1,054.98%
1.17B
311.13%
1.23B
5.12%
821.78M
33.22%
net cash used provided by financing activities
-347.32M
-
311.29M
189.63%
-1.01B
425.41%
2.35B
332.35%
-1.62B
169.02%
-753.68M
53.61%
effect of forex changes on cash
-118K
-
362K
406.78%
232K
35.91%
-64.00M
27,685.78%
-35.10M
45.16%
15.12M
143.09%
net change in cash
83.25M
-
615.06M
638.81%
-832.84M
235.41%
2.92B
450.06%
-2.30B
178.79%
684.46M
129.80%
cash at beginning of period
489.33M
-
572.58M
17.01%
1.19B
107.42%
354.80M
70.13%
3.27B
821.70%
973.14M
70.24%
1.66B
70.34%
cash at end of period
572.58M
-
1.19B
107.42%
354.80M
70.13%
3.27B
821.70%
973.14M
70.24%
1.66B
70.34%
1.66B
0%
operating cash flow
939.08M
-
775.82M
17.39%
772.80M
0.39%
96.73M
87.48%
-201.97M
308.80%
1.35B
770.75%
capital expenditure
-292.20M
-
-335.22M
14.72%
-507.66M
51.44%
-352.84M
30.50%
-209.49M
40.63%
-678.00M
223.65%
free cash flow
646.88M
-
440.60M
31.89%
265.14M
39.82%
-256.11M
196.59%
-411.46M
60.66%
676.71M
264.47%

All numbers in (except ratios and percentages)